Axar.az
UP
14 December 2018


China approves 17 anti-cancer drugs

Home page World
12 Punto 14 Punto 16 Punto 18 Punto

China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said, part of its efforts to make cancer treatment more affordable as the number of cases increases.

Axar.az reports citing Reuters.

China’s State Medical Insurance Administration has been in negotiations with domestic and overseas pharmaceutical companies to lower prices and put more cancer drugs on the list of medicines eligible for reimbursement.

The administration said in a notice that the negotiations were a major part of the government’s strategy to make cancer drugs more affordable to the general public. The 17 drugs, which include azacitidine, will remain eligible until Nov. 30, 2020.

China’s cancer rates have been soaring, driven by growing numbers of over-60s, heavy smoking among men and exposure to pollution. The National Cancer Center said last year there were 4.29 million new cases every year and 2.81 million deaths.

China has vowed to improve the five-year cancer survival rate by 15 percentage points by 2030. The rate stood at 30 percent in 2015, half the U.S. level.

Date
2018.10.10 / 10:50
Author
Axar.az
Comments
See also

Koreas agree to hold for rail, road reconnection

Production of Kalashnikov guns launched in India in 2019

Mexico's president did not discuss border wall with Trump

Russian PM hopes to sign visa agreement with Belarus

Ford set to end production at Blanquefort site in France

EU court of justice rules against passport checks

Number of corruption crimes doubled

Cyberpirates hack foreign ministry webpage

2 Israelis killed in West Bank shooting

Two officers stabbed in old city of Jerusalem

Latest
 
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla